Company Update: Pfizer Inc (NYSE:PFE) – Pfizer wins EU approval for $15 bln Hospira buy

[Reuters] – U.S. drugmaker Pfizer gained European Union antitrust approval on Tuesday for its proposed $15 billion acquisition of U.S. rival Hospira after pledging to sell some drugs to allay competition concerns. “The . . . → Read More: Company Update: Pfizer Inc (NYSE:PFE) – Pfizer wins EU approval for $15 bln Hospira buy Similar Articles: Market Update: Amgen Inc (NASDAQ:AMGN) – Amgen wins first approval for new class of cholesterol drugs Company Update: Reynolds American Inc (NYSE:RAI) – Reynolds American wins U.S. antitrust approval to buy rival Lorillard Company Update (NYSE:ACE): ACE Aviation reports 2014 annual results, announces intent to seek Court approval for a $115 million distribution to shareholders and provides an update on its liquidation process